Celltrion
068270.KS
#815
Rank
S$40.35 B
Marketcap
S$175.96
Share price
0.16%
Change (1 day)
12.46%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): S$3.27

According to Celltrion 's latest financial reports the company's current EPS (TTM) is S$3.21. In 2025 the company made an earnings per share (EPS) of S$3.93 an increase over its 2024 EPS that were of S$1.49.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$3.27-16.9%
2025S$3.93163.66%
2024S$1.49-53.73%
2023S$3.22-2.08%
2022S$3.29-11.72%
2021S$3.732.03%
2020S$3.6582.8%
2019S$2.0018.31%
2018S$1.69-36.33%
2017S$2.65161.25%
2016S$1.022.86%
2015S$0.9917.84%
2014S$0.845.87%
2013S$0.79-70.85%
2012S$2.72134.09%
2011S$1.1643.59%
2010S$0.8174.49%
2009S$0.46317.8%
2008S$0.11-71.7%
2007S$0.39